Meeting
2014 ASCO Annual Meeting
A comparison between 5-fluorouracil/mitomycin (FM) and capecitabine/mitomycin (CM) in combination with radiation (RT) for squamous cell carcinoma (SCC) of the anal canal.
Authors
Dante D.C. Wan
BC Cancer Agency, Vancouver Centre, Vancouver, BC, Canada
Dante D.C. Wan , Devin Schellenberg , John Hay , Howard John Lim , Renata D'Alpino Peixoto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Highlights Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Anal Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 4031)
DOI
10.1200/jco.2014.32.15_suppl.4031
Abstract #
4031
Poster Bd #
50
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
A 20-year comparison of definitive chemoradiation with 5-FU versus capecitabine in anal cancer patients treated at Stanford.
First Author: Yoanna S Pumpalova
Poster
2012 Gastrointestinal Cancers Symposium
Intensity-modulated radiation therapy (IMRT) with concurrent chemotherapy for anal cancer: A large single-institution experience.
First Author: Melissa Pulfer Mitchell
Poster
2017 Gastrointestinal Cancers Symposium
Long-standing Crohn’s disease and its implication on anal squamous cell cancer management.
First Author: Sara Moncrief
Poster
2011 Gastrointestinal Cancers Symposium
Cisplatin (C) based chemoradiation (CXRT) for locally advanced squamous cell carcinoma (SCCA) of the anal canal (AC): A 20-year perspective.
First Author: Cathy Eng